KJ
Katherine Jackman
Non Executive Director at NRG Therapeutics
Greater Melbourne Area
Overview
Katherine Jackman is an Investment Manager at Brandon Capital Partners in Melbourne, with a strong background in cell biology, molecular biology, and biochemistry. She has held key roles such as Chief Operating Officer at Athena Medicines Pty Ltd and has served as a Board Observer for several healthcare companies, showcasing her expertise in the industry and strategic decision-making skills.
Work Experience
Board Observer
2023 - Current
Non Executive Director
2023
Board Observer
2022 - 2023
Investment Manager
2016
Board Observer
2019
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.
Raised $92,000,000.00 from Evonik Venture Capital, Arboretum Ventures, Pavilion Capital, WTT Investment, Vertex Growth Fund, Vertex Ventures HC, New Enterprise Associates, Brandon Capital and Temasek Holdings.
Board Observer
2022 - 2022
Chief Operating Officer
2017 - 2020
Research Fellow
2014 - 2017
MRCF Intern
2016 - 2016
Postdoctoral Fellow
2009 - 2013
Weill Cornell Medicine is an academic medical institution that offers health care services.
Raised $53,500,000.00 from National Cancer Institute, National Institutes of Health, UnitedHealthcare and National Institutes of Health.